Literature DB >> 8792542

Choosing a nuclear medicine study for cardiovascular applications.

W H Moore1.   

Abstract

One of the strongest points of the field of nuclear medicine has been its ability to adapt to the development of new drugs, new machines, and changing clinical needs. As in many other areas of medicine, however, this progression makes it difficult for the occasional user to stay abreast of the latest offerings in the field. This article provides some background and guidelines to assist in the selection of radioisotopic procedures for cardiovascular applications, with the goal of directing the study to an individual patient's needs.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8792542      PMCID： PMC325325     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


  16 in total

1.  Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues.

Authors:  L M Buja; A J Tofe; P V Kulkarni; A Mukherjee; R W Parkey; M D Francis; F J Bonte; J T Willerson
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

2.  Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection.

Authors:  I Carrió; L Berná; M Ballester; M Estorch; D Obrador; M Cladellas; L Abadal; M Ginjaume
Journal:  J Nucl Med       Date:  1988-12       Impact factor: 10.057

3.  Factors affecting ventricular volumes determined by a count-based equilibrium method.

Authors:  E C Fearnow; J A Stanfield; R J Jaszczak; C C Harris; R E Coleman
Journal:  J Nucl Med       Date:  1985-09       Impact factor: 10.057

4.  The influence of ectopic heart beats in gated ventricular blood-pool studies.

Authors:  H M Brash; P K Wraith; W J Hannan; N G Dewhurst; A L Muir
Journal:  J Nucl Med       Date:  1980-04       Impact factor: 10.057

5.  First-pass radionuclide assessment of right and left ventricular performance in patients with cardiac and pulmonary disease.

Authors:  H J Berger; R A Matthay; L M Pytlik; A Gottschalk; B L Zaret
Journal:  Semin Nucl Med       Date:  1979-10       Impact factor: 4.446

6.  Sources of variability in the radionuclide angiographic assessment of ejection fraction: a comparison of first-pass and gated equilibrium techniques.

Authors:  S Kaul; C A Boucher; R D Okada; J B Newell; H W Strauss; G M Pohost
Journal:  Am J Cardiol       Date:  1984-03-01       Impact factor: 2.778

7.  Radionuclide measurement of left ventricular volume: comparison of geometric and counts-based methods.

Authors:  B M Massie; B L Kramer; E W Gertz; S G Henderson
Journal:  Circulation       Date:  1982-04       Impact factor: 29.690

8.  Validation of left ventricular volume measurements by radionuclide angiography.

Authors:  M S Verani; J Gaeta; A D LeBlanc; L R Poliner; L Phillips; J L Lacy; J I Thornby; R Roberts
Journal:  J Nucl Med       Date:  1985-12       Impact factor: 10.057

9.  Patterns of evolution of myocyte damage after human heart transplantation detected by indium-111 monoclonal antimyosin.

Authors:  M Ballester-Rodés; I Carrió-Gasset; L Abadal-Berini; D Obrador-Mayol; L Bernà-Roqueta; J M Caralps-Riera
Journal:  Am J Cardiol       Date:  1988-09-15       Impact factor: 2.778

10.  Real-time radionuclide cineangiography in the noninvasive evaluation of global and regional left ventricular function at rest and during exercise in patients with coronary-artery disease.

Authors:  J S Borer; S L Bacharach; M V Green; K M Kent; S E Epstein; G S Johnston
Journal:  N Engl J Med       Date:  1977-04-14       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.